Evidence map›Paper›PMID 41993176›Full record

ArticleFrontiers in immunology2026

Exploring medication adherence and illness perception in patients with neuroimmune diseases: a cross-sectional study.

Ruizi Fu, Xiaofei Wang, Ziyan Shi, Rui Wang, Hongyu Zhou

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruizi FuWest China School of Medicine, Sichuan University, Chengdu, China.
Xiaofei WangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Ziyan ShiDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Rui WangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Hongyu ZhouDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Neuroimmune diseases (NIDs) including myasthenia gravis (MG), multiple sclerosis (MS), and neuromyelitis optica spectrum disorder (NMOSD) require long-term medication adherence to optimize prognosis. This study aimed to investigate factors influencing medication adherence and its association with illness perception among NIDs patients. Methods: A cross-sectional survey was conducted at the Outpatient Department of Neurology, West China Hospital, Sichuan University, from March to August 2025. Patients with clinically diagnosed MG, MS, or NMOSD and ≥ 6 months of treatment were enrolled. The questionnaire on basic information, the Eight-Item Morisky Medication Adherence Scale (MMAS-8), and the Brief Illness Perception Questionnaire (BIPQ) were used for data collection. SPSS 27.0, Prism and hiplot.cn were used for statistical analysis and illustration. Results: A total of 137 valid questionnaires were collected via face-to-face interviews. Univariate analyses showed significant differences in illness perception ( Conclusion: Illness perception and average income are key factors affecting medication adherence in NIDs patients, with diseases and income disparities. Individualized education targeting cognitive and emotional perceptions, along with economic considerations in treatment, may improve long-term outcomes.

Indexed as

Medication AdherenceMultiple SclerosisMyasthenia GravisNeuromyelitis OpticaAdultCross-Sectional StudiesDrug MonitoringFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedPerceptionSurveys and Questionnairesillness perceptionmedication adherencemultiple sclerosismyasthenia gravisneuroimmune diseasesneuromyelitis optica spectrum disorder

Identifiers

PMID41993176
PMCPMC13079056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.